Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

• Status: Recruiting
• Trial end date: 2023-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to determine whether Super-Bolus is more effective in postprandial glycemic control than Normal-Bolus after the high glycemic index (H-GI) meal in children with type 1 diabetes (T1DM) treated with insulin pump (continuous subcutaneous insulin infusion, CSII).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Warsaw
• Treatments: Insulin; Insulin Aspart; Insulin glulisine; Insulin Lispro; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• duration of type 1 diabetes longer than 12months,

• insulin pump therapy longer than 3 months,

• written informed consent to participate in the study signed by parents (and patient older than 16 years).

Exclusion Criteria:

• celiac disease,

• diabetes related complications (e.g. nephropathy),

• BMI at or above the 95th percentile and at or below 3rd percentiles for children and teenagers of the same age and sex,

• withdrawal of consent to participate in the study,

• comorbid conditions and treatment which could significantly affect glycemic values in the researchers' opinion.